Education
About Us
Working with TipRanks
Follow Us
Merit Medical Systems (MMSI)
NASDAQ:MMSI
MMSI Analyst Ratings
Strong Buy
6 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MMSI Stock 12 Month Forecast
Average Price Target
$100.57
▲(16.39% Upside)
| Highest Price Target$109.00 | Average Price Target$100.57 | Lowest Price Target$90.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bank of America Securities
$90
Hold
4.15%
Upside
Reiterated
12/01/25
Hold Rating for Merit Medical Systems Due to Pending Long-term Data and Pricing Challenges for WRAPSODY StentWe spoke with an interventional radiologist at a large hospital in Miami who performs ~120 dialysis access maintenance procedures annually, with volumes growing 5-10% per year. Covered stents represent about 30% of cases in their practice, and utilization has increased following the introduction of WRAPSODY. The physician began using WRAPSODY roughly six months ago. 75-80% of their stent cases have transitioned to the device from GORE, citing favorable early outcomes and availability of larger diameter sizes. While initial cases have been positive with no occlusions reported to date, the doctor noted that long-term durability data will take years to develop. They expect WRAPSODY to become the SOC in their practice barring any new complications or competitive data. This call was more positive than our WRAPSODY check last week (see note).
Wells Fargo
$103→$95
Buy
9.94%
Upside
Reiterated
11/14/25
Canaccord Genuity
$104→$93
Buy
7.63%
Upside
Reiterated
11/14/25
Barrington
$106
Buy
22.67%
Upside
Reiterated
11/14/25
Needham
$108
Buy
24.99%
Upside
Reiterated
11/14/25
Piper Sandler
$109
Buy
26.14%
Upside
Reiterated
11/14/25
Robert W. Baird
$102→$103
Buy
19.20%
Upside
Reiterated
10/31/25
Raymond James
$108→$102
Buy
18.04%
Upside
Reiterated
07/31/25
J.P. Morgan
$95
Buy
9.94%
Upside
Reiterated
07/31/25
Sidoti
$122
Buy
41.19%
Upside
Reiterated
07/08/25
Oppenheimer
$120→$116
Buy
34.24%
Upside
Reiterated
02/26/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
$90
Hold
4.15%
Upside
Reiterated
12/01/25
Hold Rating for Merit Medical Systems Due to Pending Long-term Data and Pricing Challenges for WRAPSODY StentWe spoke with an interventional radiologist at a large hospital in Miami who performs ~120 dialysis access maintenance procedures annually, with volumes growing 5-10% per year. Covered stents represent about 30% of cases in their practice, and utilization has increased following the introduction of WRAPSODY. The physician began using WRAPSODY roughly six months ago. 75-80% of their stent cases have transitioned to the device from GORE, citing favorable early outcomes and availability of larger diameter sizes. While initial cases have been positive with no occlusions reported to date, the doctor noted that long-term durability data will take years to develop. They expect WRAPSODY to become the SOC in their practice barring any new complications or competitive data. This call was more positive than our WRAPSODY check last week (see note).
Wells Fargo
$103→$95
Buy
9.94%
Upside
Reiterated
11/14/25
Canaccord Genuity
$104→$93
Buy
7.63%
Upside
Reiterated
11/14/25
Barrington
$106
Buy
22.67%
Upside
Reiterated
11/14/25
Needham
$108
Buy
24.99%
Upside
Reiterated
11/14/25
Piper Sandler
$109
Buy
26.14%
Upside
Reiterated
11/14/25
Robert W. Baird
$102→$103
Buy
19.20%
Upside
Reiterated
10/31/25
Raymond James
$108→$102
Buy
18.04%
Upside
Reiterated
07/31/25
J.P. Morgan
$95
Buy
9.94%
Upside
Reiterated
07/31/25
Sidoti
$122
Buy
41.19%
Upside
Reiterated
07/08/25
Oppenheimer
$120→$116
Buy
34.24%
Upside
Reiterated
02/26/25
Best Analysts Covering Merit Medical Systems
1 Month
xxx
Success Rate
22/31 ratings generated profit
Average Return
+4.49%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 70.97% of your transactions generating a profit, with an average return of +4.49% per trade.
3 Months
xxx
Success Rate
25/31 ratings generated profit
Average Return
+10.14%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 80.65% of your transactions generating a profit, with an average return of +10.14% per trade.
1 Year
Success Rate
20/31 ratings generated profit
Average Return
+19.93%
reiterated a buy rating 5 months ago
Copying Jayson Bedford's trades and holding each position for 1 Year would result in 64.52% of your transactions generating a profit, with an average return of +19.93% per trade.
2 Years
xxx
Success Rate
34/51 ratings generated profit
Average Return
+12.32%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +12.32% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MMSI Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
0
0
0
0
0
Buy
24
26
17
18
15
Hold
4
4
2
1
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
28
30
19
19
18
Each month's total comprises the sum of three months' worth of ratings.
MMSI Financial Forecast
MMSI Stock Forecast FAQ
What is MMSI’s average 12-month price target, according to analysts?
Based on analyst ratings, Merit Medical Systems’s 12-month average price target is 100.57.
What is MMSI’s upside potential, based on the analysts’ average price target?
Merit Medical Systems has 16.39% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MMSI a Buy, Sell or Hold?
Merit Medical Systems has a consensus rating of Strong Buy which is based on 6 buy ratings, 1 hold ratings and 0 sell ratings.
What is Merit Medical Systems’s price target?
The average price target for Merit Medical Systems is 100.57. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $109.00 ,the lowest forecast is $90.00. The average price target represents 16.39% Increase from the current price of $86.41.
The highest analyst price target is $109.00 ,the lowest forecast is $90.00. The average price target represents 16.39% Increase from the current price of $86.41.
What do analysts say about Merit Medical Systems?
Merit Medical Systems’s analyst rating consensus is a Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
How can I buy shares of MMSI?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.